Use of panaxadiol group saponin in preparing anti-shock medicine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JILIN UNIV
- Publication Date
- 2005-10-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The invention belongs to a new medical application field of effective ingredients of traditional Chinese medicine. Background technique
[0002] Shock is referred to as "surgery" in the "Guidelines for the Pharmacology of New Chinese Medicines". This category of syndromes includes "hemorrhagic shock", "septic shock", "cardiogenic shock", "anaphylactic shock", "Traumatic shock" and so on. Shock is a common syndrome or pathological process secondary to a variety of diseases, and is a clinical crisis.
[0003] "Dushen Decoction" has a long history of being used in the treatment of "Jietuo". Ginsenosides are saponins extracted from traditional Chinese medicine ginseng. Solvent extraction and column chromatography were used to separate Panaxadiol Saponins (PDS) and Panaxatriol Saponins (PTS). PDS is a dammarane-type tetracyclic triterpene saponins, mainly composed of ginsenosides Rb1, Rb2, Rb3, Rc, Rd, etc. Its molecular structure combines 3 to 4 molecules of su...